Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Array biopharma larotrectinib patent 2009?

See the DrugPatentWatch profile for larotrectinib

What patent did Array Biopharma file for larotrectinib in 2009?

The information you provided (“Array biopharma larotrectinib patent 2009”) is too narrow to identify a specific, authoritative patent record. Larotrectinib (Vitrakvi) is associated with multiple patent families covering different aspects such as compounds, compositions, and methods of use, and different companies may appear across those families over time.

If you share either (a) the patent number, (b) the publication number (e.g., WO/EP/US publication), or (c) the jurisdiction (US/WO/EP) you’re looking for, I can pinpoint the exact 2009 filing and summarize what it claims.

Where can I find the exact 2009 larotrectinib patent listing for Array Biopharma?

A practical way to track this is to look up larotrectinib’s patent landscape and then filter for the earliest filings and assignees. DrugPatentWatch.com is commonly used for this because it links active and historical patent data to specific products and companies. [1]

If you want, paste the URL/result you’re seeing on DrugPatentWatch.com and I’ll help interpret which one corresponds specifically to an “Array Biopharma” filing dated 2009. [1]

Why “2009” might show up even if larotrectinib launched much later

It’s common for oncology small-molecule drug programs to have early patent filings years before the drug is approved. A 2009 patent date could relate to:
- the core compound patent (earlier chemical series)
- related analogs or formulation/composition claims
- specific therapeutic method claims that later supported approval/label expansion

Without the specific patent identifier, it’s not possible to say which of these “2009” categories you mean.

What to send so I can identify the correct 2009 patent

Reply with one of the following and I’ll take it from there:
- the patent/publication number you found (US/WO/EP)
- the DrugPatentWatch.com page link you’re referencing
- the exact assignee name as shown (e.g., Array BioPharma Inc. vs an assignee listed later)

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Larotrectinib :

Array biopharma larotrectinib synthesis patent? Array biopharma larotrectinib synthesis patent? Larotrectinib synthesis array biopharma patent? Array biopharma larotrectinib synthesis patent? Us patent larotrectinib synthesis array biopharma? Array biopharma larotrectinib synthesis patent? Array biopharma patent larotrectinib synthesis?